Pensionfund DSM Netherlands acquired a new position in Colgate-Palmolive (NYSE:CL) during the third quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 58,000 shares of the company’s stock, valued at approximately $4,225,000.

Several other hedge funds have also recently added to or reduced their stakes in CL. Proficio Capital Partners LLC increased its stake in Colgate-Palmolive by 16.9% during the 1st quarter. Proficio Capital Partners LLC now owns 1,432 shares of the company’s stock valued at $107,000 after buying an additional 207 shares during the period. OLD Second National Bank of Aurora acquired a new position in Colgate-Palmolive during the 2nd quarter valued at about $109,000. Krilogy Financial LLC increased its stake in Colgate-Palmolive by 23.0% during the 2nd quarter. Krilogy Financial LLC now owns 1,547 shares of the company’s stock valued at $115,000 after buying an additional 289 shares during the period. Hanson & Doremus Investment Management increased its stake in Colgate-Palmolive by 4.5% during the 2nd quarter. Hanson & Doremus Investment Management now owns 1,630 shares of the company’s stock valued at $121,000 after buying an additional 70 shares during the period. Finally, Captrust Financial Advisors acquired a new position in Colgate-Palmolive during the 2nd quarter valued at about $122,000. 72.96% of the stock is currently owned by institutional investors and hedge funds.

In other Colgate-Palmolive news, COO Justin Skala sold 126,393 shares of the firm’s stock in a transaction dated Thursday, November 9th. The shares were sold at an average price of $72.97, for a total value of $9,222,897.21. Following the completion of the transaction, the chief operating officer now directly owns 262,361 shares in the company, valued at $19,144,482.17. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, CMO Mukul Deoras sold 7,500 shares of the firm’s stock in a transaction dated Friday, November 10th. The stock was sold at an average price of $73.28, for a total transaction of $549,600.00. Following the completion of the transaction, the chief marketing officer now owns 45,217 shares of the company’s stock, valued at $3,313,501.76. The disclosure for this sale can be found here. Insiders sold a total of 173,673 shares of company stock worth $12,629,293 in the last ninety days. Corporate insiders own 1.02% of the company’s stock.

Several equities analysts have commented on CL shares. Jefferies Group reissued a “hold” rating and set a $79.00 target price on shares of Colgate-Palmolive in a research note on Thursday, August 24th. Macquarie started coverage on shares of Colgate-Palmolive in a research note on Thursday, September 14th. They set a “neutral” rating and a $76.00 target price on the stock. Zacks Investment Research cut shares of Colgate-Palmolive from a “hold” rating to a “sell” rating in a research note on Wednesday, September 20th. Morgan Stanley raised shares of Colgate-Palmolive from an “equal weight” rating to an “overweight” rating and raised their target price for the company from $75.00 to $84.00 in a research note on Monday, September 25th. Finally, Royal Bank of Canada reissued a “hold” rating and set a $74.00 target price on shares of Colgate-Palmolive in a research note on Sunday, October 8th. Two research analysts have rated the stock with a sell rating, fifteen have issued a hold rating and four have issued a buy rating to the stock. The company has a consensus rating of “Hold” and an average price target of $76.04.

Colgate-Palmolive (CL) opened at $73.35 on Thursday. The stock has a market cap of $63,653.85, a P/E ratio of 25.26, a PEG ratio of 3.32 and a beta of 0.81. The company has a quick ratio of 0.92, a current ratio of 1.23 and a debt-to-equity ratio of 24.42. Colgate-Palmolive has a 52 week low of $63.43 and a 52 week high of $77.27.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, October 27th. The company reported $0.73 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.73. The company had revenue of $3.97 billion for the quarter, compared to analysts’ expectations of $3.94 billion. Colgate-Palmolive had a net margin of 15.10% and a return on equity of 2,782.56%. The business’s revenue was up 2.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.73 EPS. research analysts expect that Colgate-Palmolive will post 2.88 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, November 15th. Stockholders of record on Monday, October 23rd were paid a $0.40 dividend. The ex-dividend date of this dividend was Friday, October 20th. This represents a $1.60 annualized dividend and a dividend yield of 2.18%. Colgate-Palmolive’s dividend payout ratio is currently 61.78%.

COPYRIGHT VIOLATION NOTICE: This report was posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this report on another website, it was illegally stolen and republished in violation of international copyright laws. The correct version of this report can be read at https://www.thecerbatgem.com/2017/12/14/pensionfund-dsm-netherlands-acquires-new-holdings-in-colgate-palmolive-cl.html.

Colgate-Palmolive Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Stock Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related stocks with our FREE daily email newsletter.